Posts

Showing posts with the label Breast Cancer

2023 Advances in Breast Cancer Treatment: Breakthroughs from ASCO Clinical Trials

Image
  The 2023 American Society for Clinical Oncology (ASCO) annual clinical meeting in cancer research showcased groundbreaking advances in Breast Cancer treatment. Among the plethora of clinical trial updates, two stand out as game-changers. Firstly, CDK4/6 inhibitors are taking a prominent position in Breast Cancer therapy.  Cyclin-dependent kinase 4 and 6 (CDK4 and CDK6) are enzymes important in cell division.  CDK4/6 inhibitors are drugs designed to interrupt the growth of cancer cells.  CDK4/6 inhibitors are used in combination with hormone therapy to treat some Breast Cancers.  These inhibitors block cancer cells' growth cycle, preventing cancer progression, and were initially developed as a treatment option for endocrine therapy-resistant Breast Cancer.  Palbociclib (Ibrance®) received American FDA approval in 2015, followed by ribociclib (Kisqali®) and abemaciclib (Verzenio®) in 2017 and in the UK NICE approved it in 2018.  Researchers presented trials with these inhibitors

Mbodies Pink Ribbon – Trains the UK’s Breast Cancer Exercise specialists with its Pilates based Post Operative Rehabilitation Course. By Chris Onslow

Image
The Pink Ribbon Breast Cancer Rehabilitation course will prepare Pilates Instructors to qualify and be certified as a Breast Cancer Exercise specialist. Overview of Breast Cancer in the UK   One in nine women will be diagnosed with Breast Cancer at some time in their life and according to the UK Office of National Statistics Breast Cancer is the most common form of cancer in England. More than 11,500 people will die of Breast Cancer every year.   Over 600,000 people who have been treated for Breast Cancer are currently living in the UK.    For many thousands of women who have survived Breast Cancer the disease will return, and the cycle of treatment and decision making will start all over again,  the return of the cancer may or may not be related to the first incidence. In 2010 there were approximately 50,000 new cases of Breast Cancer in women and 400 cases in men with the highest incidence in the 60 to 70-year-old age range.  Less than 20% of all Breast Cancer new diagnoses are in wo

The first face-to-face Mbodies, post rehab breast cancer course, since lockdown - the prequel.

Image
  ‘Spot the difference’ As we prepared on Saturday Morning 26 th June 2021 for Mbodies Training Academy’s  first face-to-face education since lockdown, it felt a bit like setting up a 'spot the difference' game:  6 Physiotherapists, 7 Pilates Instructors a Yoga specialist instructor and an advanced fitness professional were about to arrive for two days of Pink Ribbon Post-Rehab Instructor Training and what would in 2019 have been just a routine set-up was anything but that today. The arrival The Arrival No more lonely sign-in Sheet to greet you – instead ‘Lateral-Flow’ Covid 19 tests for those who had not brought photographic proof of their own negative test earlier that morning. .  Type IIR medical-grade disposable masks: the new requirement to be admitted to the course; as well as the compulsory sanitiser to use when entering and leaving the premises! The sign-in The Disclaimers and Waivers Added to the normal disclaimer and permission  forms covering liability, data-prote